Evogene is a computational biology company. Co.'s segments are: Agriculture, which includes its division and subsidiaries engaged in agricultural activities, including seed traits activity, ag-chemicals activity (through its subsidiary, AgPlenus Ltd.) and ag-biologicals activity (through its subsidiary, Lavie Bio Ltd.); Human Health, which focuses on discovery and development of human microbiome-based therapeutics (through its subsidiary, Biomica Ltd.) and cannabis activity (through its subsidiary, Canonic Ltd.); and Industrial applications, which focuses on the development and commercialization of improved castor bean seeds for industrial uses (through its subsidiary, Casterra Ag Ltd.). The EVGN YTD return is shown above.
The YTD Return on the EVGN YTD return page and across the coverage universe of our site,
is a measure of the total return for a given investment year-to-date for the current calendar year
(up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement
period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely
useful in the context of our country's tax system which taxes gains and income on a calendar year basis.
Thus, researching Year-To-Date Returns is good practice for investors — whether EVGN YTD return or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the EVGN YTD return calculation (with any dividends reinvested as applicable), and to provide a
coverage universe of many stocks and ETFs to be able to compare YTD returns.
|